![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/26/2904407/0/en/Altimmune-Mourns-Passing-of-Chief-Financial-Officer-Richard-Eisenstadt.html
https://www.fiercebiotech.com/biotech/altimmune-touts-best-class-lean-mass-results-weight-loss-therapy-quest-outdo-big-time
https://www.globenewswire.com/news-release/2024/06/20/2901589/0/en/Altimmune-to-Participate-in-the-Piper-Sandler-2nd-Annual-Virtual-Obesity-Investor-Day-to-Discuss-ADA-Takeaways.html
https://www.globenewswire.com/news-release/2024/06/05/2893731/0/en/Altimmune-Presents-Data-at-EASL-International-Liver-Congress-2024-Supporting-the-Disease-Modifying-Potential-and-Differentiated-Therapeutic-Profile-of-Pemvidutide-in-Metabolic-Dysf.html
https://www.globenewswire.com/news-release/2024/05/29/2889752/0/en/Altimmune-to-Participate-at-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/29/2889737/0/en/Altimmune-to-Present-Clinical-Data-from-Pemvidutide-at-Upcoming-EASL-International-Liver-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/09/2878586/0/en/Altimmune-Announces-First-Quarter-2024-Financial-Results-and-Provides-a-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/07/2876602/0/en/Altimmune-to-Participate-at-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/02/2874074/0/en/Altimmune-to-Report-First-Quarter-2024-Financial-Results-and-Provide-Business-Update-on-May-9-2024.html